Bio-Techne TECH Instruments — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Techne's instruments — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Techne's instruments — revenue?
- Bio-Techne (TECH) reported instruments — revenue of $27.66M in Q1 2026.
- How has Bio-Techne's instruments — revenue changed year-over-year?
- Bio-Techne's instruments — revenue increased by 5.9% year-over-year, from $26.11M to $27.66M.
- What is the long-term trend for Bio-Techne's instruments — revenue?
- Over 4 years (2021 to 2025), Bio-Techne's instruments — revenue has grown at a 4.6% compound annual growth rate (CAGR), from $93.78M to $112.09M.
- What does instruments — revenue mean?
- The total net revenue generated from the sale of analytical instruments to customers.
- How do you interpret instruments — revenue?
- An increase suggests strong demand for the company's hardware platforms and successful market penetration of its analytical tools, while a decrease may indicate market saturation, longer sales cycles, or increased competition in the capital equipment sector.
- How does instruments — revenue compare across companies?
- Comparable to 'Equipment Revenue' or 'Hardware Sales' reported by other life sciences tools and diagnostics companies, though comparability depends on the specific mix of analytical versus diagnostic instrumentation.